Bukwang Pharm.Co., Ltd. – Product Pipeline Review – 2014 adds report “Bukwang Pharm.Co., Ltd. – Product Pipeline Review – 2014” to its store.

Bukwang Pharm.Co., Ltd. Product Pipeline Review 2014′, provides an overview of the Bukwang Pharm.Co., Ltd.’s pharmaceutical research and development focus.


This report provides comprehensive information on the current therapeutic developmental pipeline of Bukwang Pharm.Co., Ltd.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.


Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.


Complete report available @ .


The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.


Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.




·         The report provides brief overview of Bukwang Pharm.Co., Ltd. including business description, key information and facts, and its locations and subsidiaries

·         The report reviews current pipeline of Bukwang Pharm.Co., Ltd.’s human therapeutic division and enlists all their major and minor projects

·         The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones

·         Special feature on out-licensed and partnered product portfolio

·         The report summarizes all the dormant and discontinued pipeline projects

·         Latest company statement

·         Latest news and deals relating to the Bukwang Pharm.Co., Ltd.’s pipeline products


Reasons to buy


·         Evaluate Bukwang Pharm.Co., Ltd.’s strategic position with total access to detailed information on its product pipeline

·         Assess the growth potential of Bukwang Pharm.Co., Ltd. in its therapy areas of focus

·         Identify new drug targets and therapeutic classes in the Bukwang Pharm.Co., Ltd.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas

·         Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps

·         Develop strategic initiatives by understanding the focus areas of Bukwang Pharm.Co., Ltd. and exploit collaboration and partnership opportunities

·         Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

·         Plan mergers and acquisitions effectively by identifying the most promising pipeline of Bukwang Pharm.Co., Ltd.

·         Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

·         Explore the dormant and discontinued projects of Bukwang Pharm.Co., Ltd. and identify potential opportunities in those areas

·         Avoid Intellectual Property Rights related issues


Inquire for Discount @ .

(This is a premium report priced at US$1500 for a single user PDF.)


List of Tables


Bukwang Pharm.Co., Ltd., Key Information 4

Bukwang Pharm.Co., Ltd., Key Facts 4

Bukwang Pharm.Co., Ltd. - Pipeline by Indication, 2014 6

Bukwang Pharm.Co., Ltd. - Pipeline by Stage of Development, 2014 7

Bukwang Pharm.Co., Ltd. - Monotherapy Products in Pipeline, 2014 8

Bukwang Pharm.Co., Ltd. - Partnered Products in Pipeline, 2014 9

Bukwang Pharm.Co., Ltd. - Partnered Products/ Combination Treatment Modalities, 2014 10

Bukwang Pharm.Co., Ltd. - Filing rejected/Withdrawn, 2014 11

Bukwang Pharm.Co., Ltd. - Phase I, 2014 12

Bukwang Pharm.Co., Ltd. - Unknown, 2014 13

Bukwang Pharm.Co., Ltd. - Pipeline by Target, 2014 20

Bukwang Pharm.Co., Ltd. - Pipeline by Route of Administration, 2014 21

Bukwang Pharm.Co., Ltd. - Pipeline by Molecule Type, 2014 22

Bukwang Pharm.Co., Ltd. - Pipeline Products by Mechanism of Action, 2014 23

Bukwang Pharm.Co., Ltd. - Recent Pipeline Updates, 2014 24

Bukwang Pharm.Co., Ltd. - Dormant Developmental Projects,2014 25

Bukwang Pharm.Co., Ltd. - Discontinued Pipeline Products, 2014 26


Purchase a copy of this report @ .


About Us: is your single source for all market research needs. Our database includes 450,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets. We offer you customization options on reports by & custom reports through With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.